Internal Medicine, Nephrology · San Francisco, CA
NPI
1124139167
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
521 Parnassus Ave, Clinical Sciences, Room C443
San Francisco, CA, 94143
Phone (415) 476-2172
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
1,993 services
Medicare patients, 2024
246
Average age 71
Drug cost, 2024
$833K
941 prescriptions
Company payments, 2025
$57K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond K Hsu was code 99215 (office e&m - established), 202 times for 93 patients. In total Raymond K Hsu billed 1,993 services in 28 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 202 | 93 | $120.55 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 181 | 61 | $104.70 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 144 | 56 | $70.16 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 78 | 63 | $14.62 | $1,140 |
| 90945 Peritoneal Dialysis | Facility | 74 | 26 | $77.91 | $5,765 |
| 90962 ESRD Related Services (not dialysis) | Office | 56 | 11 | $186.49 | $10K |
| 99442 Telephone Services | Facility | 24 | 17 | $50.35 | $1,208 |
| 99223 Hospital E&M - Initial | Facility | 24 | 23 | $153.57 | $3,686 |
| 99222 Hospital E&M - Initial | Facility | 23 | 22 | $115.75 | $2,662 |
| 90935 Hemodialysis | Facility | 23 | 22 | $62.58 | $1,439 |
| 50200 Other Organ Systems | Facility | 16 | 16 | $111.50 | $1,784 |
| 99205 Office E&M - New | Facility | 11 | 11 | $161.55 | $1,777 |
By year: 2022 $113K for 1,343 services; 2023 $107K for 956 services; 2024 $101K for 1,993 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raymond K Hsu prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 93 prescriptions and refills. In total Raymond K Hsu wrote 941 Medicare prescriptions that cost $833K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 93 | 197 | 24 | $104K |
| Furosemide Generic | 62 | 167 | 18 | $452 |
| Amlodipine Besylate Generic | 61 | 179 | 21 | $402 |
| Losartan Potassium Generic | 43 | 127 | 16 | $574 |
| Telmisartan Generic | 42 | 109 | 15 | $1,617 |
| Sevelamer Carbonate Generic | 41 | 93 | Under 11 | $33K |
| Jardiance Empagliflozin | 40 | 95 | 11 | $53K |
| Carvedilol Generic | 31 | 83 | 12 | $366 |
| Bumetanide Generic | 28 | 80 | 11 | $2,196 |
| Atorvastatin Calcium Generic | 24 | 72 | Under 11 | $136 |
| Lisinopril Generic | 23 | 69 | Under 11 | $198 |
| Metoprolol Succinate Generic | 22 | 56 | Under 11 | $291 |
| Labetalol Hcl Generic | 21 | 57 | Under 11 | $1,671 |
| Spironolactone Generic | 20 | 60 | Under 11 | $265 |
| Omeprazole Generic | 19 | 54 | Under 11 | $251 |
Brand drugs: 238 claims; generic drugs: 703 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond K Hsu $57K ($57K in general payments such as food, travel and fees) from 12 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $43K.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 13 | $43K |
| Travere Therapeutics, Inc. TVTX | 23 | $12K |
| Novo Nordisk Inc NVO | 1 | $1,908 |
| Amgen Inc. AMGN | 2 | $167 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $143 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $108 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $103 |
| Calliditas Therapeutics US Inc. | 1 | $64.78 |
| GlaxoSmithKline, LLC. GSK | 1 | $24.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.